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Abstract
Histone lysine (K) methylation has been shown to play a fundamental role in modulating chromatin architecture and
regulation of gene expression. Here we report on the identification of histone H3K56, located at the pivotal, nucleosome
DNA entry/exit point, as a novel methylation site that is evolutionary conserved. We identify trimethylation of H3K56
(H3K56me3) as a modification that is present during all cell cycle phases, with the exception of S-phase, where it is
underrepresented on chromatin. H3K56me3 is a novel heterochromatin mark, since it is enriched at pericentromeres but
not telomeres and is thereby similar, but not identical, to the localization of H3K9me3 and H4K20me3. Possibly due to H3
sequence similarities, Suv39h enzymes, responsible for trimethylation of H3K9, also affect methylation of H3K56. Similarly,
we demonstrate that trimethylation of H3K56 is removed by members of the JMJD2 family of demethylases that also target
H3K9me3. Furthermore, we identify and characterize mouse mJmjd2E and its human homolog hKDM4L as novel,
functionally active enzymes that catalyze the removal of two methyl groups from trimethylated H3K9 and K56. H3K56me3 is
also found in C. elegans, where it co-localizes with H3K9me3 in most, but not all, tissues. Taken together, our findings raise
interesting questions regarding how methylation of H3K9 and H3K56 is regulated in different organisms and their functional
roles in heterochromatin formation and/or maintenance.
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Introduction
Histones, the building blocks of chromatin, are subject to several
posttranslational modifications including methylation, acetylation
and phosphorylation that carry important functional information
[1]. Over the last decades, it has become increasingly obvious that
such chemical histone tags contribute to the regulation of DNA-
related processes in a highly selective and specialized manner [2].
These posttranslational histone modifications (PTMs) either change
nucleosome structure directly by affecting histone-DNA contacts or
indirectly by recruiting PTM-binding proteins that act on the
underlying chromatin structure, as has been proposed in the
‘‘histone code’’ hypothesis [3]. Although most marks are found on
the flexible histone tail regions, some modifications have also been
identified on core residues. One such core PTM, histone H3 lysine
56 acetylation (H3K56ac) [4], occurs in the a-N-helical region near
the entry-exit sites of the DNA superhelix and is conserved from
yeast to man [5]. It is most abundant during S phase [6,7] and has
been shown to play a pivotal role in DNA damage response [6],
chromatin integrity [8,9] and replication-coupled nucleosome
assembly [10]. In a previous mass spectrometry-based study, we
were not only able to verify the existence of H3K56 acetylation in
humans but were also able to identify low levels of mono- and
trimethylation of lysine 56 on histone H3 (H3K56me1 and
H3K56me3, respectively) [11]. Recently, it was demonstrated that
monomethylation of H3K56 regulates DNA replication through
interaction with the replication processivity factor PCNA and is
catalyzed by the lysine methyltransferase (KMT) G9a (KMT1C)
[12]. The involvement of H3K56me1 in such an important
biological event led us to ask how trimethylation of this residue
might be regulated and impact cellular processes. Despite the known
in vivo existence of H3K56me3 [11], no further information
concerning this novel histone H3 core modification has been
established. We set out to learn more about its functional role by
deciphering its chromatin localization and by identifying enzymes
that set (‘‘writer’’) and erase (‘‘eraser’’) this mark.
Materials and Methods
Cell lines
Human HeLa Kyoto cells [13], and mouse C127 (ATCC CRL-
1616) cell lines were grown inDMEMmedium (PAA) supplemented
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with 10%FCS (Sigma) and 1%penicillin/streptomycin at 37uCand
5% CO2. Wild type, Suv39hDKO [14] and SUV4-20hDKO [15]
mouse embryonic fibroblast (MEF) cell lines were grown in DMEM
medium (PAA) supplemented with 18% FCS (Sigma), 1% penicil-
lin/streptomycin, 1% non-essential amino acids (Invitrogen),
50 mM b-mercaptoethanol and 0.4% LIF at 37uC and 5% CO2.
Cells were transfected using FuGene HD (Roche Applied Science)
according to the manufacturer’s instructions.
Antibodies
Polyclonal rabbit antibody against H3K56me3 was developed
by Pineda Antiko¨rper-Service (Berlin, Germany) using a peptide
with the following amino acid sequence for immunization and
affinity purification: NH2-CRRYQ-K(me3)-STEL-CONH2. Com-
mercially available antibodies used in this study include: Primary
antibodies: aH3 (C-terminus, Abcam), aH4 (Antikoerper-online),
aH3K4me2 (Abcam), aH3K4me3 (Abcam), aH3K9me1 (Milli-
pore), aH3K9me2 (Active Motif), aH3K9me3 (Active Motif and
[16]; specificity tests are shown in Figure S1), aH3K27me2
(Millipore), aH3K27me3 (Millipore), aH3K36me1 (Millipore),
aH3K36me2 (Active Motif), aH3K36me3 (Abcam), aH4K20me1
(Millipore), aH4K20me2 (Millipore), aH4K20me3 (Abcam),
aH3K56me1 (Millipore), aH3K56me2 (Active Motif), aH3K56ac
(Active Motif). Secondary antibodies: for immunoblots (Amer-
sham), for IF microscopy (Dianova).
Peptide competition experiment
aH3K56me3 antibody in 1:1000 or 1:100 dilutions was
preincubated with 2 mg/ml of peptides (Table S1) before usage
in either immunoblots or immunofluorescence (IF) microscopy,
respectively. Peptides were N-terminally biotinylated and synthe-
sized with higher than 80% purity by The Rockefeller University,
GeneScript or the MPI for Biochemistry Munich. In case of
immunoblots, acid extracted histones [17] and recombinant
histone H3 [18] were used.
Figure 1. Determination of aH3K56me3 specificity and suitability in diverse applications. (A) Immunoblot peptide competition
experiment. aH3K56me3 antibody was preincubated with competitor peptides before addition to immunoblots containing recombinant H3 protein
(R) or acid extracted HeLa Kyoto histones (H) (top). Ponceau staining (bottom) serves as loading control. (B) IF microscopy peptide competition
experiment. aH3K56me3 antibody (green) was preincubated with competitor peptides before addition to fixed HeLa Kyoto cells. DAPI (blue) stains
DNA. Scale bar = 5 mm. (C) Spot-blot with different concentrations (5–1000 ng) of H3 peptides to determine aH3K56me3-binding affinities. (D)
Immunoblot of sequential tryptic digest of HeLa Kyoto-derived mononucleosomes using aH3K56me3 (top), aH3K9me3 (middle) and aH3 (bottom).
FL = full-length histone H3, GD = N-terminally deleted globular domain of histone H3.
doi:10.1371/journal.pone.0051765.g001
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Tryptic digest of mononucleosomes
66107 HeLa Kyoto cells were incubated in PBS, 0.3% Triton
X-100 and Protease Inhibitor Cocktail (Roche, Germany) for
10 min at 4uC. Nuclei were pelleted, washed once in PBS,
resuspended in EX100 buffer (10 mM Hepes pH 7.6, 100 mM
NaCl, 1.5 mM MgCl2, 0.5 mM EGTA, 10% (v/v) glycerol,
10 mM b-glycerol phosphate, 1 mM DTT, Protease Inhibitor
Cocktail (Roche, Germany)) and CaCl2 concentration adjusted to
2 mM. Resuspended nuclei were digested with 1.5 U MNase
(Sigma) for 20 min at 26uC. The reaction was stopped by addition
of EGTA to a final concentration of 10 mM followed by
centrifugation for 10 min at 1000 rcf, 4uC. Mononucleosome
containing supernatant was retained. NH4HCO3 was added at a
final concentration of 50 mM or until a pH of 7–8 was
reached.1.6 mg Trypsin (Promega) was added and the reaction
was incubated at 25uC. Samples were collected at different time
points and the reaction stopped by adding an equal volume of 1%
trifluoroacetic acid. Fragments were size separated on a 15% SDS-
PAGE probed with indicated antibodies.
Spot-blot
Peptide dilutions containing 2, 10, 50, 200 and 1000 ng in
sterile water were spotted on nitrocellulose membrane and allowed
to air-dry. The membrane was then blocked in PBS-Tween (0.1%)
with milk powder (5%), followed by immunoblotting with
aH3K56me3.
Immunofluorescence (IF) microscopy and cell cycle
analysis
Mammalian cells. Preparation of mammalian cells and
chromosome spreads for IF microscopy was done as previously
reported [19]. Staining of S-phase cells was performed as
Figure 2. H3K56me3 is evolutionary conserved, has a cell-cycle independent appearance and is part of pericentromeric
heterochromatin. (A) Immunoblot with acid extracted histones from human (HeLa Kyoto), mouse (MEF) and fly (S2) cell lines using aH3K56me3
(top) and, as loading control, aH4 (bottom) antibodies. (B) IF analysis of H3K56me3 (top) and H3K56ac (bottom) appearance in G1/G2 and S-phase
cells. C127 cells were pulse-labeled with EdU (red) to visualize replication foci and to identify cells in S-phase. Cells were co-stained with aH3K56me3
or aH3K56ac (green) and DAPI (DNA, blue). Scale bar = 5 mm. (C) IF microscopy of MEF cells in interphase and different stages of mitosis co-stained
with aH3K56me3 (red), aH4K20me3 (red) and DAPI (DNA, blue). Scale bar = 5 mm. (D) IF of chromosome spread from nocodazole-arrested HeLa cells
with aH3K56me3 (red) and DAPI (DNA, blue) staining. Scale bar = 5 mm.
doi:10.1371/journal.pone.0051765.g002
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described in [18]. Wide-field IF imaging of EdU-stained C127
cells was performed on a PersonalDV microscope system (Applied
Precision) equipped with a 606/1.42 PlanApo oil objective
(Olympus), CoolSNAP ES2 interline CCD camera (Photometrics),
Xenon illumination and appropriate filtersets. Iterative 3D
deconvolution of image z-stacks was performed with the Soft-
WoRx 3.7 imaging software package (Applied Precision).
Confocal imaging of chromosome spreads was performed on a
TCS SP5 II microscope system (Leica Microsystems, Wetzlar,
Germany), equipped with a 636/1.3 HCX PL APO glycerol
immersion objective. Z-stacks were recorded and subsequently
deconvolved with Huygens Essential Software (SVI, Hilversum,
The Netherlands).
Image stacks of immunostained MEF cells were collected using
a Leica TCS SP5 confocal microscope with Plan Apo Lambda
Blue 636/1.4 NA oil or 636/1.3 glycerol immersion objective.
C. elegans. Methanol/acetone fixation for immunostaining
was performed as follows. Adult hermaphrodites were dissected in
1x sperm salts with and frozen on dry-ice for 20–30 minutes. The
slides were fixed in methanol followed by acetone, 2 minutes each
wash, at 220uC. Slides were then washed once for ten minutes in
PBST prior to incubation with primary antibody [1:200 or 1:100
(direct labeling) aH3K56me3, 1:1000 aH3K9me3 (Abcam
ab8898)]. Remainder of staining protocol was conducted as
described previously [20]. Microscopy and imaging were con-
ducted as described previously [21].
Images were capture with a Hamamatsu Orca-Erga close-
coupled-device (CCD) camera mounted on an Olympus BX61
motorized Z-drive microscope using a 60X APO oil immersion
objective. These images are projections of optical sections with a Z
spacing of 0.2 micrometers. Scale bars were added using ImageJ
(available at http://rsb.info.nih.gov/ij; developed by Wayne
Rasband, National Institutes of Health, Bethesda, MD) and a
template image created in Slidebook.
Quantitative PCR
qPCR was carried out as previously described [22] using Fast
SYBR Green Master Mix (Applied Biolabs). Results were
normalized to HPRT1 and GAPDH levels.
Cloning of GFP-jmjC constructs
pDONR entry clones of the Jmjd2 subgroup [23] were
recombined into the target vector pEGFP-N1-GW using LR
clonase II enzyme mix (Invitrogen) according to the manufactur-
er’s protocol.
C. elegans RNAi
RNA interference by feeding was performed with the Ahringer
laboratory RNAi feeding library [24] in two generations as
described previously [21].
Results
Development of a specific aH3K56me3 antibody
To gain insight into the biological function(s) of H3K56
trimethylation, we raised a polyclonal antibody against
H3K56me3 (aH3K56me3) and determined its specificity in
various assays. Since H3K56me1 has previously been reported
to be catalyzed by the H3K9me1-specific KMT G9a, maybe due
to a conserved lysine-serine-threonine (K/S/T) motif at the site of
both residues [12], we put special emphasis on testing a potential
cross-reactivity of this antibody with H3K9me3. First, we
performed peptide competition experiments using peptides span-
ning diverse regions of histone H3 with or without different
methylation states. Specific antibody recognition of H3K56me3 in
immunoblotting (Figure 1A) and immunofluorescence (IF) micros-
copy (Figure 1B) was efficiently competed out only with
H3K56me3-containing peptides, but not with peptides containing
other methylated or unmethylated histone regions. Next, we
determined the relative binding affinity of aH3K56me3 to its
epitope by a peptide Spot-blot containing various concentrations
of different histone peptides and observed that aH3K56me3
detected as low as 50 ng of H3K56me3 peptides (Figure 1C).
Notably, aH3K56me3 does not recognize any other trimethylated
peptides except H3K56me3. For further support of antibody
specificity, we generated mononucleosomes from HeLa cells that
were subsequently digested with different concentrations of
Trypsin in order to generate histones lacking their flexible tail
regions. In this way, we were able to determine if the antibody
epitope resides in the H3 core region or N-terminal tail. In
Figure 3. Loss of Suv39h enzymes affect H3K56me3. IF
microscopy of wild type (WT), Suv39h double-null (Suv39h DKO) and
Suv4-20h double-null (Suv4-20h DKO) MEF cells using various H3K56 (A)
and H3K9 (B) methyl-specific antibodies (Ab-Cy3, red) and DAPI (DNA,
blue). Scale bar = 5 mm. (C) Immunoblots using acid extracted histones
from HeLa Kyoto (positive control), wild type MEF, Suv39h DKO and
Suv4-20h DKO cells. Blots were incubated with aH3K56me3 (left, top) or
aH3K9me3 (right, top) antibodies, respectively. Blots shown at the
bottom were incubated with aH4 to ensure equal loading.
doi:10.1371/journal.pone.0051765.g003
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immunoblots, aH3K56me3, but not the control aH3K9me3
antibody, recognized both full-length (FL) and the N-terminus
deleted globular domain (GD) of histone H3 (Figure 1D),
demonstrating that aH3K56me3 specifically binds to a modifica-
tion in the core region of H3. In summary, these experiments
provide compelling evidence that aH3K56me3 is highly specific
for this particular modification and can be applied in diverse
biochemical assays.
H3K56me3 is evolutionary conserved and localizes to
pericentromeric heterochromatin outside of S-phase
Having demonstrated the high specificity of aH3K56me3, we
first examined the evolutionary occurrence of this novel mark by
isolating histones from cell lines of diverse origins. Immunoblotting
revealed that H3K56me3 was present in human, mouse and fly
(Figure 2A), suggesting that this modification is conserved within,
at least, metazoans.
Given that H3K56ac is highly conserved and that methylation
and acetylation of the same residue are mutually exclusive we
wanted to investigate if there were correlations between the
appearance of one mark and disappearance of the other. While in
yeast H3K56ac has been shown to be cell cycle dependent,
showing a significant increase during S-phase, [6,9,25], its cell
cycle distribution in mammals remains controversial [26–28], with
a high possibility of its occurrence in all cell cycle phases [29].
Therefore, we analyzed cell cycle appearance and nuclear
localization of both acetylation and methylation of H3K56 in
mammalian cells. To distinguish S-phase from interphase, mouse
C127 cells were pulse-labeled with the thymidine analog EdU,
which was chemically coupled to a fluorescent dye using a ‘‘click-
chemistry’’ approach [30]. Co-staining of EdU-labeled cells with
aH3K56me3 revealed that, during interphase, H3K56me3 is
found predominantly at DAPI-dense heterochromatic chromo-
centers and shows strongly diminished signal intensity in S-phase
cells (Figure 2B top). Although, we observed a more or less equal
appearance of H3K56ac signal in interphase and S-phase cells
(Figure 2B, bottom), it is clearly distinct from the H3K56me3
signal. We also found H3K56me3 to be present throughout
mitosis (Figure 2C), where it co-localizes with heterochromatin
Figure 4. Jmjd2E demethylase affects H3K56me3. (A) IF microscopy of HeLa Kyoto cells transfected with mJmjd2E-GFP (green, left) or jmjc-
domain mutated mJmjd2E-GFP (mutant, green, right) and stained with various H3K56 and H3K9 PTM-specific antibodies (red) and DAPI (DNA, blue).
Arrows indicate transfected GFP-positive cells. Scale bar = 10 mm. See also Figure S2A for IF results of cells transfected with other GFP-tagged
mJMJD2 family members (mJmjd2a-d). (B) List of PTMs analyzed in IF after expression of mJmjd2E in HeLa Kyoto cells indicating changes in
fluorescence intensities. See also Figure S2B for examples of IF results summarized in this table. (C) qPCR analysis with cDNAs from different human
cell lines and tissues using primer pair specific for human Jmjd2E (hKDM4DL). Data were normalized to HPRT1 and GAPDH expression levels. (D) IF
microscopy of HeLa Kyoto cells transfected with human GFP-hKDM4L (green) and stained with various H3K56 and H3K9 methyl-specific antibodies
(red) and DAPI (DNA, blue). Arrows indicate transfected and GFP-positive cells. Scale bar = 10 mm.
doi:10.1371/journal.pone.0051765.g004
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foci, in an even more precise manner than the constitutive
heterochromatin marker H4K20me3 [31]. To determine
H3K56me3 localization in greater detail, human metaphase
chromosomes were analyzed in IF microscopy. In accordance
with H3K56me3 presence at chromocenters in interphase and
heterochromatin foci in mitotic cells, this modification was present
in a non-random manner and found predominantly at pericen-
tromeric heterochromatin regions that include major satellite
repeats (Figure 2D). Interestingly, H3K56me3 is, in contrast to
H3K9me3, rarely found at telomeres [32], suggesting that the
functional roles of these two modifications in heterochromatic
regions might be different.
Mammalian methyltransferase Suv39h affects
trimethylation of H3K56
To assess the functional relevance of posttranslational histone
modifications, it is important to know their responsible enzymes.
Several lysine methyltransferases (KMTs) that catalyze the
methylation of histone lysine residues have been identified
previously [33,34]. Possibly due to the fact that both regions
surrounding H3K56 and H3K9 contain a conserved K/S/T
motif, monomethylation of H3K56 has been shown to be
catalyzed by the H3K9me1-specific KMT G9a [12]. Additionally,
both H3K9me3 and H3K56me3 localize to similar, albeit not
identical, nuclear domains suggesting that H3K9 and H3K56
might share the same KMTs responsible for their trimethylation.
Therefore, we first tested the H3K9me3-specific KMTs Suv39h1/
2 (KMT1A and B) [35] for their ability to affect the methylation
status of H3K56. Interestingly, we observed a complete loss of
both H3K56me3 and H3K9me3 signals at chromocenters in
Suv39h double-null MEF cells (Suv39h DKO, [14]). Accompa-
nied with this loss of trimethyl signals, we observed an increase of
the respective monomethyl marks at chromocenters (Figure 3A
and B). This dramatic change in PTM localization upon the
simultaneous lack of Suv39h1/2 suggests that these enzyme are
involved in catalyzing trimethylation of both H3K9 and H3K56,
the latter in either a direct or indirect manner. Since H3K56me3
showed a somewhat similar nuclear appearance as H4K20me3
Figure 5. H3K56me3 is conserved in Caenorhabditis elegans. Shown are representative IF microscopy pictures from adult C. elegans
hermaphrodite tissues. In all images H3K56me3 is shown in green, H3K9me3 in red, and DAPI (DNA) in blue. Scale bar = 5 mm. A) H3K56me3 co-
localizes with H3K9me3 in the early germline, late pachytene and in a 100-cell embryo (top picture). Interestingly, although H3K56me3 and H3K9me3
are both present in oocytes, only H3K56me3, but not H3K9me3, staining could be observed in sperm. (bottom, split channels) (B) H3K56me3 and
H3K9me3 co-localize throughout all stages of mitosis.
doi:10.1371/journal.pone.0051765.g005
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(Figure 2C), we wondered whether Suv4-20h1/h2 enzymes,
responsible for methylating lysine 20 on histone H4 [15,31],
might also target H3K56. Suv4-20h double null MEF cells (Suv4-
20h DKO, [15]) showed no difference in abundance or
localization of H3K56 methylation when compared to wild type
cells (Figure 3A and B), demonstrating that these enzymes do not
influence H3K56 methylation status. Similar results were also
obtained with immunoblots, showing that the H3K56me3 signal is
diminished in Suv39h DKO, but not Suv4-20 DKO acid
extracted histones (Figure 3C).
Jmjd2E/KDM4DL is a novel lysine-demethylase specific
for H3K9 and H3K56 trimethylation
Having shown that the same enzymes that methylate H3K9 also
affect trimethylation of H3K56, we wondered whether the erasure
of these modifications is catalyzed by identical lysine demethylases
(KDMs) as well. Histone lysines are demethylated by two different
classes of enzymes that are distinguished by their enzymatic active
domains and methylation-state specificities [36]. We focused our
attention on the Jumonji C-terminal domain (JmjC) family of
KDMs, since they are able to remove all methyl-states, including
trimethylation [37]. We therefore tested a panel of GFP-tagged
members of the JMJD2 group-containing demethylases that are
thought to partially work on H3K9me3 [23]. Over-expression of
the respective mKDM in human cells was monitored by GFP
signal in IF microscopy and effects on histone methylation were
analyzed by co-staining with different histone PTM antibodies.
This screen led to the identification of all members of the mJMJD2
family (mJmjd2A-E) able to affect H3K56me3 (Figure S2A and
Figure 4A). Since all members have previously been shown also to
act on H3K9me3 [38], our results point once again towards a
possible link between these two heterochromatic marks due, to a
shared sequence motif (K/S/T). As one example, over-expression
of mJmjd2D or mJmjd2E [39] strongly diminished H3K9me3, as
well as H3K56me3 signals, in HeLa Kyoto cells (Figure 4A, left
and Figure S2A). The loss of the respective trimethyl signal was
accompanied with an increase in the monomethyl, but not
dimethyl state, suggesting that these enzymes remove two methyl
groups in total. Since over-expression of mJmjd2D-GFP caused
severe cellular defects, its role on H3K56me3 was not further
investigated and we focused subsequent analyses on mJmjd2E that
acted solely on H3K9 and H3K56 trimethylation and not on other
histone trimethylation marks (Figure 4B and Figure S2B). The
observed changes in H3K9 and H3K56 methylation states upon
mJmjd2E-GFP over-expression were dependent on the enzymatic
active jmjC domain, since point mutations in that region
completely abolished mJmjd2E’s demethylase activity (Figure 4A,
right). In the mouse, mJmjd2E is predicted to constitute a
pseudogene and we therefore decided to analyze expression and
function of the yet uncharacterized human homolog hKDM4DL.
hKDM4DL mRNA is expressed predominantly in testis, with only
residual levels present in U2OS (osteosarcoma) and HL60
(promyelocytic leukemia) cell lines and human brain tissue
(Figure 4C). Over-expression of GFP-hKDM4DL in HeLa Kyoto
cells showed identical results as seen for the mouse homolog, loss
of H3K56 and H3K9 trimethylation with an accompanied gain of
the respective monomethylation mark (Figure 4D). Taken
together, we have identified the JMJD2 family to facilitate
demethylation of H3K9 and H3K56 trimethyl states. Additionally,
we showed that mJmjd2E, and its previously uncharacterized
human homolog hKDM4DL, specifically remove two methyl
groups from trimethylated H3K56 or H3K9 residues, depending
on their catalytically active jmjC domain.
H3K56me3 is a novel chromatin mark in C. elegans
In order to learn more about H3K56me3 evolutionary
conservation as a novel heterochromatic histone modification
and its functions, we conducted IF microscopy analysis of wild type
(WT) C. elegans hermaphrodite germlines and embryos (Figure 5A).
H3K56me3 is present in both early germline and embryonic
nuclei, as marked by DAPI morphology (Figure 5A, right). In
almost all cells analyzed, we observed an H3K56me3 signal that
strongly co-localized with H3K9me3 in most tissues (Figure 5A).
Surprisingly, H3K56me3 staining was present in both types of
germline cells, oocytes and sperm, whereas the H3K9me3 signal
was restricted to oocytes only (Figure 5A, bottom). These data
mirror previously obtained H3K9me3 results [40] and suggest that
H3K56me3 might have an important H3K9me3-independent
function in sperm development. Next, we wondered whether,
similar to mammalian cells, H3K56 is trimethylated in cells during
mitosis in C. elegans. Indeed, H3K56me3 is part of all mitotic stages
and overlaps with H3K9me3 signals (Figure 5B), demonstrating
the evolutionary high conservation of this novel mark.
Next, we sought to shed light on the enzymatic regulation of
H3K56 trimethylation in C. elegans and performed an RNAi-based
survey of known or predicted methyltransferases, including H3K9-
specific enzymes [41]. The screen included RNAi targeting MET-
2, a homolog of mammalian euchromatic H3K9 HMT SETDB1
[40–42], MET-1, a homolog of yeast Set2, an H3K36-specific
methyltransferase, whose activity was reported to be required for
normal levels of H3K9me3 [41], and SET-25, a distant homolog
G9a, recently reported to deposit H3K9me3 in C. elegans embryos
[42]. We also included RNAi against previously uncharacterized
Figure 6. C. elegans RNAi screen to identify H3K56me3-specific
KMTs. Shown are representative IF images from adult C. elegans
hermaphrodite somatic intestinal nuclei following RNAi treatment.
H3K56me3 (left) or H3K9me3 (right) staining is shown in green and
DAPI (DNA) is shown in blue. CAPG-1 co-staining was used as a staining
control (data not shown). Results show that met-1 and met-2 depletion
severely affect both H3K56me3 and H3K9me3, while reduction of
additional KMTs (set-6, set-25 and set-32) has a stronger effect on
H3K56me3 levels compared to H3K9me3. Scale bar = 5 mm.
doi:10.1371/journal.pone.0051765.g006
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SET domain containing proteins predicted to encode divergent
H3K9-specific methyltransferases (set-6, -12, -15, -20, and -32).
For control, we performed RNAi targeting an H3K4-specific
methyltransferase SET-2, a homolog of SET1/MML. We
conducted our screen in the intestine, where the large size of
nuclei makes scoring easier. This screen identified several genes
whose activity is required for normal levels of H3K56me3 and/or
H3K9me3, some of which have been previously implicated in
H3K9 methylation. H3K56me3 levels were severely reduced in
met-2 and set-25 RNAi, consistent with the requirement for these
genes for H3K9me3 levels in C. elegans embryos [42]. Interestingly,
H3K9me3 levels were less affected in these conditions, indicating
possible differences between the enzymes responsible for these
marks and/or differences in antibody sensitivities. H3K56me3
levels were also reduced in met-1 RNAi, and to a lesser extent in
set-6and set-32 RNAi. H3K9me3 levels were also reduced in met-2
and set-12 RNAi, possibly due to indirect affects (Figure 6).
H3K9me3 levels were never reduced to background levels,
perhaps due to partial redundancy between these enzymes.
Knockdown of other known H3K9 methyltransferases or the
H3K4 KMT set-2 resulted in DAPI perturbations, but showed no
effect on H3K56me3 staining (Figure 6).
In sum, H3K56me3, its relationship to H3K9me3, and its
regulation by several H3K9 methyltransferases are conserved in C.
elegans. However, some degree of divergence in the factors
regulating H3K56me3 may have occurred in C. elegans.
Discussion
Our study establishes the existence of a novel pericentric
heterochromatin mark, H3K56me3, in several metazoan species.
This novel modification is present in all cell cycle phases, with the
exception of S-phase, where it is underrepresented. Enzymes
targeting H3K9 also act on H3K56, as the KMTs Suv39h1/2 are
important for trimethylation of both residues and KDM JMJD2
family members remove these modifications. Mouse Jmjd2E and
its so far uncharacterized human homolog hKDM4DL are
involved in the process of demethylating H3K56me3 to a
monomethylated status. In C. elegans, H3K56me3 is a conserved
feature of mitotic chromosomes that primarily co-localizes with
H3K9me3 and is regulated by some but not all H3K9
methyltransferases.
Of particular interest is our observation in mammalian cells that
H3K56me3 is found in chromocenters containing pericentric
heterochromatin, but only outside of S-phase. During that
particular cell cycle phase, H3K56me3-specific IF microscopy
signals are strongly diminished. Such an effect can be caused either
by a replication-specific removal of the trimethylation mark or by
occlusion of the epitope through adjacent modifications, such as
phosphorylation of H3S57, or association with a binding protein.
As H3K56 is targeted by the lysine acetyltransferases CBP or
GCN5 [26,43] prior to being deposited onto DNA during
replication [7,44,45], it is highly likely that newly synthesized
H3 histones with K56ac replace ‘‘old’’ H3K56me3-containing
ones. Given that H3K56me3 has been recently shown to prevent
binding of PCNA that specifically associates with the mono-
methylation state [12], it is plausible that H3K56me3 needs to be
removed during replication to allow proper action of PCNA at the
replication forks. With regard to adjacent modification sites, a
serine and a threonine, potential phosphorylation sites, are located
next to lysine 56. Although H3S57 phosphorylation was reported
to exist in mammals in vivo [46], no data on its appearance during
cell cycle, on responsible enzymes and its function in mammals are
available due to the lack of a specific antibody. One study,
applying yeast mutants proposes a potential functional interplay
between H3K56 and S57 in replicative stress recovery and
transcriptional elongation [46]. However, because H3S57ph has
thus far not been identified in yeast in vivo, it is not possible to
relate such observations to the mammalian system. Concerning
putative H3K56me3-specific binding partners, we applied peptide
pull-down experiments followed by MS identification of precip-
itated proteins (data not shown). Although we repeated such
experiment many times, we were not able to consistently pull-
down any candidates when compared to unmodified control
peptide pull-downs. It is likely that H3K56me3 is not directly
recognized by any ‘‘reader’’ protein but, instead functions
indirectly by preventing acetylation of H3K56 and its associated
signaling pathways. Alternatively, since H3K56me3 is localized in
the a-N-helical region near the entry-exit sites of the DNA
superhelix, it is possible that the correctly folded three-dimensional
structure of this region (alone or in combination with DNA or
other histones) is crucial for reader binding. Therefore, the use of
peptides in such pull-down experiments will not suffice in reader
binding. H3K56me3 histones or even nucleosomes containing this
PTM will be needed for the identification of its potential reader(s)
in the future.
Our finding that H3K56me3 constitutes another heterochro-
matin mark is in perfect agreement with previously published data,
since H3K56 is monomethylated by G9A [12] that was initially
described as a KMT responsible for H3K9me1 and H3K9me2
[47]. It is therefore plausible that H3K9me3-specific KMT(s)
might also act on H3K56. We report here that the loss of Suv39h
enzymes leads to diminished trimethylation of both H3K56 as well
as H3K9. Based on our experimental set-up using Suv39h double-
null cells, it is at the moment not possible to exclude that loss of
H3K56me3 stems from an indirect effect. The chance of
H3K9me3 influencing trimethylation of H3K56 by an, as yet,
unknown mechanism, is conceivable albeit unlikely. Several
observations argue for a direct enzymatic action of Suv39h on
H3K56; the presence of a ‘‘K/S/T’’ motif in both regions and the
fact that G9a, another H3K9-specific KMT is the responsible
enzyme for H3K56me1 [12]. Therefore, we propose that Suv39h
enzymes directly trimethylate H3K56 leading to a pericentric
heterochromatin localization.
Although like both H3K9me3 and H4K20me3, H3K56me3
also constitutes a mark found in DAPI-dense regions, these
modifications are not identical in their localization when looked at
in greater detail. H3K9me3 stains telomeric repeats [32] and our
results indicate that the majority of H3K56me3 does not. In
contrast to H4K20me3, we found H3K56me3 in distinct
chromatin foci during all mitotic phases, indicating that this novel
mark is found in much more distinct heterochromatic loci. We
plan to investigate this finding in future studies.
Besides our discovery of a novel histone modification site, our
study raises one important question for many researchers dealing
with PTMs and their biological functions. The finding that some
enzymes might have several targets is supported by another recent
study showing that pericentric localization of H3K64me3, another
H3 core modification, also depends on Suv39h activity [48].
Therefore, the observed severe knock-down [14] and over-
expression [49] phenotypes that were previously assigned to the
sole loss or gain of H3K9me3, respectively, have to be reevaluated,
since Suv39h enzymes affect not only H3K9, but also H3K64 as
well as H3K56 trimethylation, It is possible that the assigned role
of H3K9me3 in protecting genome stability and heterochromatic
gene silencing [50] is in part shared by H3K56me3.
In agreement with the finding that H3K9-specific KMTs act on
H3K56, we demonstrated a strong correlation between both
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residues as to their KDM-specificity. Our study expands the list of
known histone target residues of enzymes belonging to the JMJD2
family of demethylases since we could show that they act not only
on H3K9me3 and, in some cases, H3K36me3 [38], but also on
H3K56me3. Of particular interest is our characterization of
mJmjd2E, a predicted pseudogene and its human homolog
hKDM4DL, which codes for a, so far, uncharacterized protein.
Because of hKDM4DL’s strongest expression in human testis, it
will be of great interest to determine if and why removal of the
trimethylation of H3K9 and H3K56 is important in this special
tissue. Perhaps it is crucial during the process of histone-protamine
exchange and/or relaxation of pericentric heterochromatin in
humans; a statement that will be difficult to address since the
mouse enzyme is predicted to be a pseudogene and not expressed.
hKDM4DL might, therefore, constitute a human or primate-
specific protein. If so, then functional studies on hKDM4DL in
testis will be hard, if not impossible to perform.
Our study clearly puts forward H3K56me3 as a novel
modification, but we were unable to address its functional
relevance. Usually, knock-down of the enzymes targeting the
respective modification provide insights into its biological role; but
since H3K9 and H3K56 methylations are affected by the same
enzymatic machinery in mammals, we do not have any technical
tool at hand to pinpoint, in vivo, one particular phenotype to
H3K56me3. However, identification of genes that affect the two
modifications slightly differently in the C. elegans intestine opens up
the possibility of future functional studies, at least in this particular
organism.
Interestingly, we identified MET-1, a H3K36 KMT homolog,
as needed for wild type levels of both H3K9me3 and H3K56me3.
It was previously suggested that H3K36 methylation might be a
prerequisite for H3K9me3 in worms [41], and perhaps it is
similarly required for H3K56me3 as well. Previous studies
reported that H3K9me3 in the germline is independent of
MET-2 [40], however H3K9me3 levels are significantly reduced
in MET-2-depleted embryos [42]. These results indicate that
different KMTs might be primarily used in different tissues.
Consistent with this hypothesis, depletion of MET-2 and SET-25
significantly reduces H3K9me3 levels in embryos [42], and
H3K56me3 levels in the intestine (this study), but their effect is
less pronounced for H3K9me3 levels in the intestine. Future
studies will be needed to reveal how the preference for different
KMTs is regulated in different tissues.
We identified multiple KMTs required for normal levels of both
H3K9me3 and H3K56me3. One possible explanation for the
requirement of two or more methyltransferases is that one of these
KMTs deposits mono- (and perhaps di-) methylation, while the
second KMT deposits trimethylation, in a manner dependent on
prior mono- or dimethylation. This model is similar to what was
previously reported for MET-2 and SET-25 in embryos [42].
Alternative possibilities include indirect effects, perhaps involving
non-histone targets for these proteins.
Early EM studies revealed that C. elegans embryos lack electron-
dense material, classically associated with heterochromatin [51].
In addition, while in mammalian cells H3K9me3 co-localizes with
DAPI-bright regions of pericentric heterochromatin, in C. elegans,
H3K9me3 localizes to DAPI-faint regions [40], leading to the
suggestion that C. elegans lacks heterochromatin or that hetero-
chromatin is different in this species [40]. C. elegans chromosomes
are holocentric, and in the absence of a localized centromere, the
phrase ‘‘pericentric ‘‘ does not apply. Instead, the brightest foci of
H3K9me3 in C. elegans nuclei associate with the nuclear lamina
[42]. H3K9me3 is coincident with H3K27me3 and nuclear
lamina protein LEM-1, all of which are enriched along
chromosome arms [42,52]. Therefore, these regions most likely
are similar to mammalian heterochromatin near the nuclear
periphery, or lamin associated domains, LADs [53]. Our results
show that H3K56me3 colocalizes with H3K9me3 in worms,
suggesting that H3K56me3 likely marks these lamin associated
domains.
In agreement with a specialized role of H3K56me3 in testis is
the finding that sperm cells in C. elegans contain solely trimethyla-
tion of H3K56 but not of H3K9. It will be of interest to see if
H3K56me3 has an evolutionary conserved role in germline
development, although its functional implication might be
different in different metazoans.
Supporting Information
Figure S1 Immunoblot peptide competition experi-
ments to determine specificity of aH3K9me3 antibodies
used in this study. aH3K9me3 antibodies from (A) Active
Motif or (B) the Jenuwein laboratory [16] were pre-incubated with
2 mg/ml competitor peptides before addition to immunoblots
containing recombinant H3 protein (R) or acid extracted HeLa
Kyoto histones (H) (top). Ponceau staining (bottom) serves as
loading control.
(TIF)
Figure S2 Members of the JMJD2 family of demethy-
lases affect H3K56me3. (A) IF microscopy of HeLa Kyoto cells
that were transfected with GFP-tagged mJmjd2a-d and human
Jmjd2d homolog hKDM4 (green) and co-stained with
aH3K56me3 antibody (red) and DAPI (DNA, blue). Arrows
indicate transfected and GFP-positive cells. Scale bar = 10 mm.
See also Figure 4A for detailed PTM analysis of HeLa cells
transfected with mJmjd2E-GFP. (B) IF microscopy of HeLa Kyoto
cells that were transfected with mJmjd2E-GFP (green) and co-
stained with various histone PTM-specific antibodies (red) and
DAPI (DNA, blue). Arrows indicate transfected and GFP-positive
cells. Scale bar = 10 mm. See also Figure 4B that contains a listing
of the results depicted here.
(TIF)
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